Back to News
Market Impact: 0.6

Up 59%, Should You Buy ASML Right Now?

ASMLNVDAAVGOTSMJPMMSNFLXNDAQ
Technology & InnovationCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst InsightsPatents & Intellectual PropertyAntitrust & CompetitionInvestor Sentiment & Positioning
Up 59%, Should You Buy ASML Right Now?

ASML, the sole manufacturer of EUV lithography systems, reported Q3 sales of €7.51 billion (down 2.2% YoY) after selling 66 new and six used systems, with net bookings of €5.4 billion, gross profit of €3.88 billion (51.6% margin), net income of €2.12 billion and EPS €5.49. The company guided Q4 sales to €9.2–9.8 billion with margins of 51–53% and expects full-year net sales roughly 15% above 2024, while the stock has rallied ~59% YTD to a €428 billion market cap. Analyst optimism is high — JPMorgan and Morgan Stanley raised price targets (JPMorgan to $1,275), and 41 of 42 analysts are not sellers — supporting a constructive outlook for ASML into 2026.

Analysis

Market structure: ASML’s exclusive hold on EUV gives it near-monopoly pricing power for next-generation node production; winners include ASML (ASML.NV), optical suppliers (e.g., Zeiss via private exposure), and leading foundries (TSM) that secure EUV capacity. Losers are DUV-only lithography vendors and smaller fabless players unable to access EUV slots, creating a two-tier industry with >50% gross margins consolidating toward ASML. Supply/demand: bookings (~€5.4bn Q3) and guidance (+~15% FY) signal re-acceleration of capex vs earlier trough — expect backlog-driven revenue recognition over 12–24 months rather than an immediate tidal wave. Risk assessment: Tail risks include renewed export controls to China (single-event shock >-20% revenue), critical supplier failure (Zeiss optics, lasers) or laser-tin supply-chain disruptions; assign ~10–15% probability over 24 months. Immediate (days) risk = sharp profit taking; short-term (3–6 months) hinge on quarterly bookings and order cadence; long-term (2–5 years) upside tied to multi-year node migration and replacement cycles. Hidden dependencies: ASML’s margin and delivery cadence depend on single-source precision components and China demand share; watch bookings by region and supplier lead-times. Trade implications: Direct play = positive asymmetry: use 9–18 month structures (LEAPS or call spreads) to capture secular upside while capping carry. Relative-value: long ASML vs short NVDA (or semicap ETF) to isolate toolmaker vs end-market GPU cyclicality — NVDA already priced for AI and subject to product-cycle risk. Cross-asset: stronger ASML performance favors EUR strength and risk-on flows (tightening credit spreads); commodity beneficiaries include silicon wafer and specialty gases. Contrarian angles: Consensus underestimates regulatory tail risk and delivery bottlenecks; a 10%+ retracement is plausible if bookings miss by >€1bn. Valuation is rich — JPMorgan’s $1,275 PT implies ~15% upside, so prefer asymmetric structures (debit spreads, collars) over naked longs. Historical parallel: past semicap leaders outperformed into cycles but suffered 20–40% reversals on order drops; prepare stop-triggers tied to bookings and margin thresholds.